Investor update: ANGLE PLC sees head and neck cancer potential for its liquid biopsy

Headlines from the Proactive UK newsroom.

ANGLE PLC (LON:AGL,OTCQX:ANPCY) says a review of its ground-breaking liquid biopsy has identified advantages to using the technology when treating head and neck cancer patients. The Parsortix system detects the tell-tale signs of cancer in the form of circulating tumour cells found in the blood.

88 Energy Ltd (LON:88E) has updated shareholders on the progress it has made over the first half of the year, including advancing the farm-out process of Project Icewine in Alaska.  In the half-year to 30 June, the oil and gas firm selected Premier Oil as the preferred bidder for the farm-out campaign at Project Icewine’s conventional portfolio.

Utility company SSE PLC (LON:SSE) has confirmed weekend press reports that it's talking to Ovo Group about the possible sale of SSE Energy Services. The group hoisted the “for sale” sign on its energy services business back in May. The division supplies energy and related services to around 5.7mln household customers in Great Britain.

Chaarat Gold Holdings Limited (LON:CGH) has signed a joint venture with a Turkish mining contractor to collaborate on the Tulkubash and Kyzyltash projects in the Kyrgyz Republic. The AIM-listed miner said under the deal the firm will progressively invest up to US$31.5mln in cash for a 12.5% stake in the two projects.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


CBD Science Group looks to raise £2M in a Series A round to advance its...

CBD Science Group PLC CEO Dr Michael Raymont joined Proactive New York to discuss the London, England-based group's Series A funding round, on the Crowd for Angels platform. Raymont says the privately-held company, which is developing plant-based cannabinoid pharmaceutical therapeutics to...

2 hours, 30 minutes ago

2 min read